Table 1.

Logistic regression analysis of factors related to progressive disease.

Variable	Cut Off	ODDs Ratio	95% CI	FDR p Value
CCL2	>288/288	0.595	0.144–2.467	0.642
CCL3	Detected/Not detected	0.200	0.035–1.132	0.405
CCL4	>220/220	0.595	0.144–2.467	0.642
CCL7	Detected/Not detected	0.900	0.139–5.811	1.000
CCL19	>80/80	0.595	0.144–2.467	0.642
CX3CL1	>900/900	1.680	0.4054–6.962	0.642
CXCL1	>120/120	2.889	0.664–12.57	0.504
CXCL2	>145/145	0.595	0.144–2.467	0.642
CXCL10	>56/56	0.346	0.080–1.507	0.504
DKK1	>1000/1000	1.680	0.405–6.962	0.642
Fas Ligand	>45/45	1.000	0.245–4.08	1.000
Fas Receptor	>8400/8400	0.595	0.144–2.47	0.642
GDF15	>2400/2400	1.000	0.245–4.083	1.000
Granzyme B	>9/9	1.000	0.245–4.083	1.000
HGF	>100/100	1.000	0.245–4.083	1.000
IFNα	>2.1/2.1	13.330	2.24–79.44	0.021
IFNγ	>11.05/11.05	5.250	1.093–25.21	0.323
IL1β	>3.06/3.06	2.889	0.663–12.57	0.504
IL2	>6.9/6.9	1.400	0.339–5.79	0.807
IL4	>49/49	3.500	0.795–15.40	0.502
IL5	Detected/Not detected	2.000	0.244–16.36	0.681
IL6	>3.2/3.2	13.333	2.234–79.438	0.021
IL7	>2.4/2.4	0.595	0.144–2.467	0.642
IL8	>17/17	1.680	0.405–6.962	0.642
IL10	Detected/Not detected	2.022	0.475–8.434	0.642
IL12	Detected/Not detected	1.680	0.405–6.962	0.642
IL18	>260/260	1.680	0.405–6.962	0.642
MICA	>55/55	1.000	0.245–4.08	1.000
PD-L1	>18/18	0.346	0.080–1.507	0.504
TIE2	>15,300/15,300	0.286	0.065–1.257	0.502
TNFα	>5/5	0.595	0.137–2.445	0.642
TSP2	>43,000/43,000	1.679	0.405–6.962	0.642
VEGF	>30/30	1.680	0.405–6.962	0.642
VEGF-C	>480/480	1.000	0.245–4.08	1.000